Seelos Therapeutics SG&A Expense (Quarterly) Analysis

Seelos Therapeutics Inc (SEEL)

0.3385 +0.01 (+2.58%) USD | NASDAQ | May 03, 16:00

0.3385 0.00 (0.00%) After-Hours: 19:13

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2000. Upgrade now.

Date	Value
December 31, 2023	2.746M
September 30, 2023	2.987M
June 30, 2023	2.78M
March 31, 2023	4.072M
December 31, 2022	2.752M
September 30, 2022	2.66M
June 30, 2022	2.883M
March 31, 2022	4.001M
December 31, 2021	7.828M
September 30, 2021	2.227M
June 30, 2021	2.465M
March 31, 2021	2.50M
December 31, 2020	2.013M
September 30, 2020	2.07M
June 30, 2020	1.876M
March 31, 2020	1.816M
December 31, 2019	1.132M
September 30, 2019	1.415M
June 30, 2019	1.69M
March 31, 2019	3.322M
December 31, 2018	6.206M
September 30, 2018	0.915M
June 30, 2018	2.075M
March 31, 2018	2.135M
December 31, 2017	2.411M

Date	Value
September 30, 2017	1.756M
June 30, 2017	1.602M
March 31, 2017	1.441M
December 31, 2016	1.90M
September 30, 2016	1.55M
June 30, 2016	2.122M
March 31, 2016	2.224M
December 31, 2015	2.339M
September 30, 2015	2.412M
June 30, 2015	2.669M
March 31, 2015	3.096M
December 31, 2014	2.763M
September 30, 2014	2.719M
June 30, 2014	2.877M
March 31, 2014	3.059M
December 31, 2013	3.108M
September 30, 2013	2.866M
June 30, 2013	3.754M
March 31, 2013	3.826M
December 31, 2012	5.027M
September 30, 2012	3.755M
June 30, 2012	3.317M
March 31, 2012	3.24M
December 31, 2011	2.586M
September 30, 2011	2.272M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.132M

Minimum

Dec 2019

7.828M

Maximum

Dec 2021

2.732M

Average

2.50M

Median

Mar 2021

SG&A Expense (Quarterly) Benchmarks